REQUEST A DEMO
Total
USD $0.00
Search more companies

Diagnostico Especializado Por Citometria de Flujo S.A.S (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Diagnostico Especializado Por Citometria de Flujo S.A.S Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

The company Diagnostico Especializado Por Citometria De Flujo Ltda is primarily engaged in ambulatory health care services and related activities. It's been operating in the Colombian market since 2010.

Headquarters
Calle 71 # 11-10 Oficina 201 Edificio Corecol
Bogota D.C.; Bogota D.C;

Contact Details: Purchase the Diagnostico Especializado Por Citometria de Flujo S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Diagnostico Especializado Por Citometria de Flujo S.A.S report to view the information.
Outstanding Shares:
Purchase the Diagnostico Especializado Por Citometria de Flujo S.A.S report to view the information.
Incorporation Date:
February 17, 2010
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
80%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Diagnostico Especializado Por Citometria de Flujo S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
16.41%
Total operating revenue
16.41%
Operating profit (EBIT)
42.9%
EBITDA
39.71%
Net Profit (Loss) for the Period
60.73%
Total assets
61.82%
Total equity
55.86%
Operating Profit Margin (ROS)
5.3%
Net Profit Margin
4.48%
Return on Equity (ROE)
2.87%
Debt to Equity Ratio
29.13%
Quick Ratio
0%
Cash Ratio
-0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?